Condensed Consolidated Statements of Stockholders' Equity (Deficit) (Unaudited) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss
Beginning balance (in shares) at Dec. 31, 2021		97,961,597
Beginning balance at Dec. 31, 2021	$ 217,045	$ 10	$ 641,406	$ (424,112)	$ (259)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(121,086)			(121,086)
Other comprehensive loss, net of tax	(6,312)				(6,312)
Stock-based compensation	20,645		20,645
Issuance of common stock for acquisitions (in shares)		628,660
Issuance of common stock for acquisitions	3,552		3,552
Contingent consideration for acquisitions	530		530
Vesting of restricted stock awards (in shares)		1,871,584
Exercise of stock options (in shares)		472,215
Exercise of stock options	1,108		1,108
Income tax withholdings (in shares)		(523,731)
Income tax withholdings	(2,879)		(2,879)
Ending balance (in shares) at Sep. 30, 2022		100,410,325
Ending balance at Sep. 30, 2022	112,603	$ 10	664,362	(545,198)	(6,571)
Beginning balance (in shares) at Jun. 30, 2022		99,440,528
Beginning balance at Jun. 30, 2022	194,543	$ 10	659,814	(460,722)	(4,559)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(84,476)			(84,476)
Other comprehensive loss, net of tax	(2,012)				(2,012)
Stock-based compensation	5,089		5,089
Vesting of restricted stock awards (in shares)		1,062,323
Exercise of stock options (in shares)		197,758
Exercise of stock options	416		416
Income tax withholdings (in shares)		(290,284)
Income tax withholdings	(957)		(957)
Ending balance (in shares) at Sep. 30, 2022		100,410,325
Ending balance at Sep. 30, 2022	112,603	$ 10	664,362	(545,198)	(6,571)
Beginning balance (in shares) at Dec. 31, 2022		98,206,323
Beginning balance at Dec. 31, 2022	79,353	$ 10	670,537	(585,023)	(6,171)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(131,447)			(131,447)
Other comprehensive loss, net of tax	(1,472)				(1,472)
Stock-based compensation	20,277		20,277
Vesting of restricted stock awards (in shares)		2,295,474
Exercise of stock options (in shares)		11,564
Exercise of stock options	10		10
Income tax withholdings (in shares)		(634,880)
Income tax withholdings	(991)		(991)
Repurchases of common stock (in shares)		(1,396,158)
Repurchases of common stock	(3,101)			(3,101)
Proceeds from sale of common stock	191		191
Ending balance (in shares) at Sep. 30, 2023		98,482,323
Ending balance at Sep. 30, 2023	(37,180)	$ 10	690,024	(719,571)	(7,643)
Beginning balance (in shares) at Jun. 30, 2023		98,168,956
Beginning balance at Jun. 30, 2023	(36,742)	$ 10	683,151	(713,827)	(6,076)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(5,744)			(5,744)
Other comprehensive loss, net of tax	(1,567)				(1,567)
Stock-based compensation	6,979		6,979
Vesting of restricted stock awards (in shares)		372,514
Exercise of stock options (in shares)		7,045
Exercise of stock options	2		2
Income tax withholdings (in shares)		(66,192)
Income tax withholdings	(108)		(108)
Ending balance (in shares) at Sep. 30, 2023		98,482,323
Ending balance at Sep. 30, 2023	$ (37,180)	$ 10	$ 690,024	$ (719,571)	$ (7,643)